Filing Details
- Accession Number:
- 0000950170-24-053667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-06 17:02:30
- Reporting Period:
- 2024-05-03
- Accepted Time:
- 2024-05-06 17:02:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1111485 | Rxsight Inc. | RXST | Ophthalmic Goods (3851) | 943268801 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1295469 | Md M Ronald Kurtz | C/O Rxsight, Inc. 100 Columbia Aliso Viejo CA 92656 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-05-03 | 40,000 | $60.15 | 764,610 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 40,000 | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
- Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $60.00 to $60.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
Billionaire Hedge Funds
